Pharmaceutical Executive-07-01-2014

Column
Pharmaceutical Executive

July 23, 2014

Pharma backs federal standards for compassionate use, drug importing, data transparency, and track-and-trace. Jill Wechsler reports.

Pharmaceutical Executive
Column

July 21, 2014

FDA officials willing to relocate to far-flung global cities should be congratulated for their herculean efforts to protect American patients. But funding cuts hamper the Agency's international presence.

Features

July 10, 2014

Its only recently that vaccine producers experienced the commercial returns commensurate with vaccines: long record of positive public health performance.

Pharmaceutical Executive

As the pacing picks up around dealmaking as the alternative to organic growth, Pharm Exec brings together experts from big Pharma and biotech to dissect the road ahead for M&A, licensing, and partnership activity.

Pharmaceutical Executive
From the Editor

July 10, 2014

A surprising takeaway from the recent BIO Convention, writes William Looney, is the stark contrast between cooperative industry engagement and an unstable geopolitical order.

Pharmaceutical Executive
Features

July 10, 2014

WebMD CEO David Schlanger tells PharmExec how connecting patients with physicians through a robust digital platform can deliver quality of care, cost savings, and better health outcomes.

Pharmaceutical Executive
Special Sponsored Section

July 01, 2014

Poland's pharma industry, the largest in Central and Eastern Europe, confronts the fallout from the government's controversial 2012 Reimbursement Act.

Pharmaceutical Executive

As companies divest non-core assets in the form of spinouts to unlock value, the role of a strong new parent brand has become increasingly important.

Cross-sector partnership seeks support for a pan-European system to keep fake drugs out, but obstacles are many.